Items where authors include "Snowden, J.A."
Article
Robin, M. orcid.org/0000-0003-1388-9876, Iacobelli, S., Koster, L. et al. (22 more authors) (2024) Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation. ISSN 0268-3369
Passweg, J.R. orcid.org/0000-0001-7092-3351, Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2024) Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT. Bone Marrow Transplantation. ISSN 0268-3369
Greco, R. orcid.org/0000-0002-6117-5328, Alexander, T., Del Papa, N. et al. (23 more authors) (2024) Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee. eClinicalMedicine, 69. 102476. ISSN 2589-5370
Lindsay, J.O. orcid.org/0000-0003-3353-9590, Hind, D. orcid.org/0000-0002-6409-4793, Swaby, L. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT. Efficacy and Mechanism Evaluation, 11 (3). ISSN 2050-4365
Sanchez-Guijo, F. orcid.org/0000-0002-7076-7739, Vives, J. orcid.org/0000-0001-9719-5235, Ruggeri, A. et al. (15 more authors) (2024) Current challenges in cell and gene therapy: a joint view from the European Committee of the International Society for Cell & Gene Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT). Cytotherapy. ISSN 1465-3249
Lindsay, J.O., Hind, D. orcid.org/0000-0002-6409-4793, Swaby, E. orcid.org/0000-0001-9443-7681 et al. (30 more authors) (2024) Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn’s disease (ASTIClite): an open-label, multicentre, randomised controlled trial. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253
Brittain, G. orcid.org/0000-0002-9903-7203, Petrie, J. orcid.org/0000-0001-6150-6724, Duffy, K.E.M. et al. (25 more authors) (2024) Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ Open, 14 (2). e083582. ISSN 2044-6055
de Tute, R.M., Cook, G. orcid.org/0000-0003-1717-0412, Cairns, D.A. orcid.org/0000-0002-2338-0179 et al. (12 more authors) (2024) Impact of minimal residual disease (MRD) in salvage autologous stem cell transplantation for relapsed myeloma: results from the NCRI Myeloma X (intensive) trial. Bone Marrow Transplantation. ISSN 0268-3369
Duque-Afonso, J. orcid.org/0000-0002-8287-5673, Finke, J. orcid.org/0000-0002-1799-5927, Ngoya, M. et al. (21 more authors) (2023) Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation. ISSN 0268-3369
Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine. ISSN 1078-8956
Kalincik, T., Sharmin, S., Roos, I. et al. (150 more authors) (2023) Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis. JAMA Neurology, 80 (7). pp. 702-713. ISSN 2168-6149
Barnes, E. orcid.org/0000-0002-0860-0831, Goodyear, C.S. orcid.org/0000-0001-5926-5941, Willicombe, M. orcid.org/0000-0002-6404-0584 et al. (154 more authors) (2023) SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease. Nature Medicine, 29 (7). pp. 1760-1774. ISSN 1078-8956
Pagliuca, S., Kulasekararaj, A.G., Eikema, D.-J. et al. (23 more authors) (2023) Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation. Haematologica. ISSN 0390-6078
Styczynski, J. orcid.org/0000-0002-3158-119X, Tridello, G., Koster, L. et al. (25 more authors) (2023) Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT. Bone Marrow Transplantation. ISSN 0268-3369
Greco, R. orcid.org/0000-0002-6117-5328, Snowden, J.A. orcid.org/0000-0001-6819-3476, Knelange, N.S. et al. (11 more authors) (2023) Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases. Journal of Autoimmunity, 136. 103024. ISSN 0896-8411
Yakoub-Agha, I. orcid.org/0000-0003-4524-8782, Greco, R. orcid.org/0000-0002-6117-5328, Onida, F. et al. (14 more authors) (2023) Practice harmonization workshops of EBMT: an expert-based approach to generate practical and contemporary guidelines within the arena of hematopoietic cell transplantation and cellular therapy. Bone Marrow Transplantation. ISSN 0268-3369
Bruno, A. orcid.org/0000-0001-8659-277X, Gurnari, C., Alexander, T. et al. (2 more authors) (2023) Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. Journal of Allergy and Clinical Immunology. ISSN 0091-6749
Tridente, A., Dempsey, N.C., Khalifa, M. et al. (8 more authors) (2023) Predicting outcomes of hematological malignancy patients admitted to critical care. Frontiers in Hematology, 2. 1127322. ISSN 2813-3935
Saccardi, R., Putter, H. orcid.org/0000-0001-5395-1422, Eikema, D.-J. et al. (45 more authors) (2023) Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation. pp. 1-8. ISSN 0268-3369
Passweg, J.R., Baldomero, H. orcid.org/0000-0002-6554-483X, Ciceri, F. et al. (12 more authors) (2023) Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT activity survey. Bone Marrow Transplantation. ISSN 0268-3369
Clark, A. orcid.org/0000-0001-9593-9528, Thomas, S., Hamblin, A. et al. (7 more authors) (2023) Management of patients with germline predisposition to haematological malignancies considered for allogeneic blood and marrow transplantation: Best practice consensus guidelines from the UK Cancer Genetics Group (UKCGG), CanGene-CanVar, NHS England Genomic Laboratory Hub (GLH) Haematological Malignancies Working Group and the British Society of Blood and Marrow Transplantation and cellular therapy (BSBMTCT). British Journal of Haematology. ISSN 0007-1048
Waszczuk-Gajda, A., Gras, L., de Wreede, L.C. orcid.org/0000-0002-7667-9369 et al. (22 more authors) (2023) Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—the DIADEM study from the chronic malignancies working party of the EBMT. Bone Marrow Transplantation. pp. 1-6. ISSN 0268-3369
Chalandon, Y. orcid.org/0000-0001-9341-8104, Sbianchi, G., Gras, L. et al. (22 more authors) (2023) Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: a retrospective study by the chronic malignancies working party of the EBMT. American Journal of Hematology, 98 (1). pp. 112-121. ISSN 0361-8609
Miller, P.D.E., Patel, S.R., Skinner, R. orcid.org/0000-0002-1162-675X et al. (9 more authors) (2023) Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA). Journal of Infection, 86 (1). pp. 1-8. ISSN 0163-4453
Doglio, M., Alexander, T., Del Papa, N. et al. (2 more authors) (2022) New insights in systemic lupus erythematosus: from regulatory T cells to CAR-T-cell strategies. Journal of Allergy and Clinical Immunology, 150 (6). pp. 1289-1301. ISSN 0091-6749
Snowden, J.A. orcid.org/0000-0001-6819-3476, Ahmedzai, S.H., Cox, A. orcid.org/0000-0002-5138-1099 et al. (9 more authors) (2022) Association of genetic variants with patient reported quality of life and pain experience in patients in the UK NCRI Myeloma X Relapse [Intensive]) trial; an exploratory study. Bone Marrow Transplantation, 57 (10). pp. 1507-1513. ISSN 0268-3369
Brittain, G. orcid.org/0000-0002-9903-7203, Coles, A.J., Giovannoni, G. orcid.org/0000-0001-9995-1700 et al. (7 more authors) (2022) Autologous haematopoietic stem cell transplantation for immune-mediated neurological diseases: what, how, who and why? Practical Neurology. ISSN 1474-7758
Duque-Afonso, J., Finke, J., Labopin, M. et al. (18 more authors) (2022) Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplantation, 57 (8). pp. 1269-1276. ISSN 0268-3369
Penny, H.A., Rej, A., Baggus, E.M.R. et al. (10 more authors) (2022) Non-responsive and refractory coeliac disease : experience from the NHS England National Centre. Nutrients, 14 (13). 2776.
Jones, G.L., Moss, R.H., Darby, F. et al. (18 more authors) (2022) Cancer, fertility and me: developing and testing a novel fertility preservation patient decision aid to support women at risk of losing their fertility because of cancer treatment. Frontiers in Oncology, 12. 896939. ISSN 2234-943X
Lawless, S., Iacobelli, S., Knelange, N.S. et al. (23 more authors) (2022) Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling. Haematologica. ISSN 0390-6078
Sharrack, B., Petrie, J., Coles, A. et al. (1 more author) (2022) Is stem cell transplantation safe and effective in multiple sclerosis? British Medical Journal (BMJ), 377. e061514. ISSN 1759-2151
Putter, H., Eikema, D.-J., de Wreede, L.C. et al. (5 more authors) (2022) Benchmarking survival outcomes: a funnel plot for survival data. Statistical Methods in Medical Research, 31 (6). pp. 1171-1183. ISSN 0962-2802
Snowden, J.A. orcid.org/0000-0001-6819-3476, Sánchez-Ortega, I., Corbacioglu, S. et al. (17 more authors) (2022) Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplantation. ISSN 0268-3369
Cartwright, A., Snowden, J.A. orcid.org/0000-0001-6819-3476, Whitehouse, H. et al. (2 more authors) (2022) Implementation of the updated NICE haematological cancers (NG47) improving outcomes guidelines across Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS) in England : a UK NEQAS LI survey. Journal of Clinical Pathology. ISSN 0021-9746
Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2022) Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplantation, 57. pp. 742-752. ISSN 0268-3369
Niederwieser, D., Baldomero, H., Bazuaye, N. et al. (33 more authors) (2022) One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors. Haematologica, 107 (5). pp. 1045-1053. ISSN 0390-6078
Drozd-Sokołowska, J., Gras, L., Zinger, N. et al. (22 more authors) (2022) Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation–study on behalf of CMWP of the EBMT. Bone Marrow Transplantation, 57 (4). pp. 633-640. ISSN 0268-3369
Hayden, P.J., Roddie, C., Bader, P. et al. (33 more authors) (2022) Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA). Annals of Oncology, 33 (3). pp. 259-275. ISSN 0923-7534
Montoto, S., Snowden, J.A. orcid.org/0000-0001-6819-3476, Chabannon, C. et al. (19 more authors) (2022) The first steps towards a diverse and inclusive EBMT: a position paper. Bone Marrow Transplantation, 57 (3). pp. 343-346. ISSN 0268-3369
Cencioni, M.T., Genchi, A., Brittain, G. orcid.org/0000-0002-9903-7203 et al. (6 more authors) (2022) Immune reconstitution following autologous hematopoietic stem cell transplantation for multiple sclerosis : a review on behalf of the EBMT autoimmune diseases working party. Frontiers in Immunology, 12. 813957.
Mawson, S. orcid.org/0000-0003-2795-8983, Keen, C., Skilbeck, J. et al. (7 more authors) (2021) Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study. Physiotherapy, 113. pp. 88-99. ISSN 0031-9406
Snowden, J.A. orcid.org/0000-0001-6819-3476, McGrath, E., Orchard, K. et al. (3 more authors) (2021) Visions for a JACIE quality management system 4.0. Bone Marrow Transplantation, 56 (12). pp. 2876-2881. ISSN 0268-3369
Marzolini, M.A.V., Mehra, V., Thomson, K.J. et al. (20 more authors) (2021) Letermovir prophylaxis in T-cell–depleted transplants: breakthrough and rebound infections in the postmarketing setting. Blood Advances, 5 (21). pp. 4500-4503. ISSN 2473-9529
Greenfield, D.M. orcid.org/0000-0002-3733-2717, Salooja, N., Peczynski, C. et al. (21 more authors) (2021) Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study. Bone Marrow Transplantation, 56 (11). pp. 2820-2825. ISSN 0268-3369
Lwin, S.M., Snowden, J.A. orcid.org/0000-0001-6819-3476 and Griffiths, C.E.M. (2021) The promise and challenges of cell therapy for psoriasis*. British Journal of Dermatology, 185 (5). pp. 887-898. ISSN 0007-0963
Alexander, T., Snowden, J.A. orcid.org/0000-0001-6819-3476, Burman, J. et al. (11 more authors) (2021) Intestinal microbiome in hematopoietic stem cell transplantation for autoimmune diseases : considerations and perspectives on behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Frontiers in Oncology, 11. 722436.
Colton, H. orcid.org/0000-0002-3287-4103, Greenfield, D.M. orcid.org/0000-0002-3733-2717, Snowden, J.A. orcid.org/0000-0001-6819-3476 et al. (6 more authors) (2021) Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant. Vaccine, 39 (34). pp. 4778-4783. ISSN 0264-410X
Das, J. orcid.org/0000-0002-9166-4624, Snowden, J.A. orcid.org/0000-0001-6819-3476, Burman, J. et al. (10 more authors) (2021) Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis. Multiple Sclerosis Journal, 27 (8). pp. 1198-1204. ISSN 1352-4585
Passweg, J.R., Baldomero, H., Chabannon, C. et al. (13 more authors) (2021) Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplantation, 56 (7). pp. 1651-1664. ISSN 0268-3369
Greco, R., Alexander, T., Burman, J. et al. (24 more authors) (2021) Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplantation, 56. pp. 1493-1508. ISSN 0268-3369
Puyade, M., Patel, A., Lim, Y.J. et al. (8 more authors) (2021) Autologous hematopoietic stem cell transplantation for Behçet’s disease: a retrospective survey of patients treated in Europe, on behalf of the autoimmune diseases working party of the European Society for Blood and Marrow Transplantation. Frontiers in Immunology, 12. 638709. ISSN 1664-3224
Burt, R.K., Tappenden, P., Balabanov, R. et al. (4 more authors) (2021) The cost effectiveness of immunoglobulin vs. hematopoietic stem cell transplantation for CIDP. Frontiers in Neurology, 12. 645263.
Greco, R., Peccatori, J., Bonifazi, F. et al. (2 more authors) (2021) Editorial: Novel immunological biomarkers for allogeneic HSCT outcome. Frontiers in Immunology, 12. 670822. ISSN 1664-3224
Dignan, F.L., Hamblin, A., Chong, A. et al. (6 more authors) (2021) Survivorship care for allogeneic transplant patients in the UK NHS : changes centre practice, impact of health service policy and JACIE accreditation over 5 years. Bone Marrow Transplantation, 56 (3). pp. 673-678. ISSN 0268-3369
Orchard, K., Dignan, F.L., Lee, J. et al. (6 more authors) (2021) The NICE COVID‐19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact. British Journal of Haematology, 192 (3). pp. 467-473. ISSN 0007-1048
Jackson, G.H., Pawlyn, C., Cairns, D.A. et al. (20 more authors) (2021) Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial. PLOS Medicine, 18 (1). e1003454. ISSN 1549-1277
Kass-Iliyya, L., Snowden, J.A. orcid.org/0000-0001-6819-3476, Thorpe, A. et al. (5 more authors) (2021) Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience. Journal of Neurology, 268 (1). pp. 265-275. ISSN 0340-5354
Roberts, F., Hobbs, H., Jessop, H. et al. (15 more authors) (2020) Rehabilitation before and after autologous haematopoietic stem cell transplantation (AHSCT) for patients with multiple sclerosis (MS): Consensus guidelines and recommendations for best clinical practice on behalf of the autoimmune diseases working party, nurses group, and patient advocacy committee of the European Society for Blood and Marrow Transplantation (EBMT). Frontiers in Neurology, 11. 556141. ISSN 1664-2295
Burt, R.K., Tappenden, P. orcid.org/0000-0001-6612-2332, Han, X. et al. (5 more authors) (2020) Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America. Multiple Sclerosis and Related Disorders, 45. 102404. ISSN 2211-0348
Schiepatti, A., Sanders, D.S., Aziz, I. et al. (16 more authors) (2020) Clinical phenotype and mortality in patients with idiopathic small bowel villous atrophy: a dual-centre international study. European Journal of Gastroenterology & Hepatology, 32 (8). pp. 938-949. ISSN 0954-691X
Das, J., Gill, A., Lo, C. et al. (6 more authors) (2020) A case of multiple sclerosis—like relapsing remitting encephalomyelitis following allogeneic hematopoietic stem cell transplantation and a review of the published literature. Frontiers in Immunology, 11. 668.
Sandler, R.D. orcid.org/0000-0002-6933-9921, Tattersall, R.S. orcid.org/0000-0002-1087-6546, Schoemans, H. et al. (14 more authors) (2020) Diagnosis and management of secondary HLH/MAS following HSCT and CAR-T cell therapy in adults; a review of the literature and a survey of practice within EBMT centres on behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP). Frontiers in Immunology, 11. 524.
Sharrack, B., Saccardi, R., Alexander, T. et al. (15 more authors) (2020) Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT autoimmune diseases working party (ADWP) and the joint accreditation committee of EBMT and ISCT (JACIE). Bone Marrow Transplantation, 55 (2). pp. 283-306. ISSN 0268-3369
Sandler, R.D. orcid.org/0000-0002-6933-9921, Carter, S., Kaur, H.. et al. (3 more authors) (2020) Haemophagocytic lymphohistiocytosis (HLH) following allogeneic haematopoietic stem cell transplantation (HSCT)—time to reappraise with modern diagnostic and treatment strategies? Bone Marrow Transplantation, 55 (2). pp. 307-316. ISSN 0268-3369
Penny, H.A. orcid.org/0000-0003-1610-2282, Baggus, E.M.R., Rej, A. et al. (2 more authors) (2020) Non-responsive coeliac disease : a comprehensive review from the NHS England national centre for refractory coeliac disease. Nutrients, 12 (1). 216.
Snowden, J.A. orcid.org/0000-0001-6819-3476, Hawkey, C., Hind, D. orcid.org/0000-0002-6409-4793 et al. (17 more authors) (2019) Autologous stem cell transplantation in refractory Crohn’s disease – low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study. BMC Gastroenterology, 19 (1). 82. ISSN 1471-230X
Walsh, J.S. orcid.org/0000-0002-7122-2650, Marshall, H., Smith, I.L. et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors : a 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277
Passweg, J.R., Baldomero, H., Basak, G.W. orcid.org/0000-0003-3858-8180 et al. (14 more authors) (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplantation, 54 (10). pp. 1575-1585. ISSN 0268-3369
Duarte, R.F., Labopin, M., Bader, P. et al. (19 more authors) (2019) Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019. Bone Marrow Transplant, 54 (10). pp. 1525-1552. ISSN 0268-3369
Miller, P.D.E., Snowden, J.A. orcid.org/0000-0001-6819-3476, De Latour, R.P. et al. (15 more authors) (2019) Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia : a joint study of the autoimmune diseases and severe aplastic anaemia working parties (ADWP/SAAWP) of the European society for blood and marrow transplantation (EBMT). Bone Marrow Transplantation. ISSN 0268-3369
Ahmedzai, S.H., Snowden, J.A. orcid.org/0000-0001-6819-3476, Ashcroft, A.J. et al. (19 more authors) (2019) Patient-reported outcome results from the open-label, randomized phase III myeloma X trial evaluating salvage autologous stem-cell transplantation in relapsed multiple myeloma. Journal of Clinical Oncology, 37 (19). pp. 1617-1628. ISSN 0732-183X
Jessop, H., Farge, D. orcid.org/0000-0002-4041-1352, Saccardi, R. et al. (12 more authors) (2019) General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant, 54 (7). pp. 933-942. ISSN 0268-3369
Das, J., Sharrack, B. and Snowden, J.A. orcid.org/0000-0001-6819-3476 (2019) Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis: a Review of Current Literature and Future Directions for Transplant Haematologists and Oncologists. Current Hematologic Malignancy Reports , 14 (2). pp. 127-135. ISSN 1558-8211
Galleu, A., Milojkovic, D., Deplano, S. et al. (21 more authors) (2019) Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival. British Journal of Haematology, 185 (1). pp. 89-92. ISSN 0007-1048
Burt, R.K., Balabanov, R., Burman, J. et al. (20 more authors) (2019) Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Journal of the American Medical Association, 321 (2). pp. 165-174. ISSN 0098-7484
Miller, P.D.E., de Silva, T.I. orcid.org/0000-0002-6498-9212, Leonard, H. et al. (6 more authors) (2019) A comparison of viral microneutralization and haemagglutination inhibition assays as measures of seasonal inactivated influenza vaccine immunogenicity in the first year after reduced intensity conditioning, lymphocyte depleted allogeneic haematopoietic stem cell transplant. Vaccine, 37 (3). pp. 452-457. ISSN 0264-410X
Striha, A., Ashcroft, A.J., Hockaday, A. et al. (12 more authors) (2018) The role of ixazomib as an augmented conditioning therapy in salvage autologous stem cell transplant (ASCT) and as a post-ASCT consolidation and maintenance strategy in patients with relapsed multiple myeloma (ACCoRd [UK-MRA Myeloma XII] trial): study protocol for a Phase III randomised controlled trial. Trials, 19. 169. ISSN 1745-6215
Paton-Hough, J., Tazzyman, S., Evans, H. et al. (6 more authors) (2018) Preventing and repairing myeloma bone disease by combining conventional antiresorptive treatment with a bone anabolic agent in murine models. Journal of Bone and Mineral Research. ISSN 0884-0431
Brierley, C.K., Castilla-Llorente, C., Labopin, M. et al. (18 more authors) (2018) Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation. Journal of Crohn's and Colitis, 12 (9). pp. 1097-1103. ISSN 1873-9946
Passweg, J.R., Baldomero, H., Bader, P. et al. (13 more authors) (2018) Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplantation , 53 (9). pp. 1139-1148. ISSN 0268-3369
Handforth, C. orcid.org/0000-0001-5171-4917, Burkinshaw, R., Freeman, J. et al. (4 more authors) (2018) Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer. Supportive Care in Cancer.
Miller, P.D.E., Forster, A.S., de Silva, T.I. orcid.org/0000-0002-6498-9212 et al. (9 more authors) (2018) Sociodemographic and psychological determinants of influenza vaccine intention among recipients of autologous and allogeneic haematopoietic stem cell transplant: a cross-sectional survey of UK transplant recipients using a modified health belief model. BMJ OPEN, 8 (8). e021222. ISSN 2044-6055
Snowden, J.A. orcid.org/0000-0001-6819-3476, Sharrack, B., Akil, M. et al. (5 more authors) (2018) Autologous haematopoietic stem cell transplantation (aHSCT) for severe resistant autoimmune and inflammatory diseases - a guide for the generalist. Clinical Medicine, 18 (4). pp. 329-334. ISSN 1470-2118
Gagelmann, N., Eikema, D.-J., Iacobelli, S. et al. (21 more authors) (2018) Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT. Haematologica, 103 (5). pp. 890-897. ISSN 0390-6078
Pockley, A.G., Lindsay, J.O., Foulds, G.A. et al. (6 more authors) (2018) Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation in Crohn's Disease: Current Status and Future Directions. A Review on Behalf of the EBMT Autoimmune Diseases Working Party and the Autologous Stem Cell Transplantation In Refractory CD Low Intensity Therapy Evaluation Study Investigators. Frontiers in Immunology, 9. 646. ISSN 1664-3224
Snowden, J.A. orcid.org/0000-0001-6819-3476, Panés, J., Alexander, T. et al. (17 more authors) (2018) Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's disease: A review on behalf of ECCO and EBMT. Journal of Crohn's and Colitis, 12 (4). pp. 476-488. ISSN 1873-9946
Shanklin, V.E., Snowden, J.A. orcid.org/0000-0001-6819-3476 and Greenfield, D.M. (2018) Late treatment effects following bone marrow transplant: Efficacy of implementing international guidelines. European Journal of Cancer Care, 27 (2). e12623. ISSN 0961-5423
Ring, E.S., Lawson, M.A., Snowden, J.A. et al. (2 more authors) (2018) New agents in the Treatment of Myeloma Bone Disease. Calcified Tissue International, 102 (2). pp. 196-209. ISSN 0171-967X
Snowden, J.A. orcid.org/0000-0001-6819-3476, Badoglio, M., Labopin, M. et al. (20 more authors) (2017) Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Advances, 1 (27). pp. 2742-2755. ISSN 2473-9529
Chinnaiya, K., Lawson, M.A. orcid.org/0000-0002-5446-923X, Thomas, S. orcid.org/0000-0002-0027-0815 et al. (8 more authors) (2017) Low-dose methotrexate in myeloproliferative neoplasm models. Haematologica, 102 (6). 165738. ISSN 0390-6078
Passweg, J.R., Baldomero, H., Bader, P. et al. (12 more authors) (2017) Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplantation, 52 (6). pp. 811-817. ISSN 0268-3369
Farge, D., Burt, R.K., Oliveira, M.C. et al. (13 more authors) (2017) Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners. Bone Marrow Transplantation . ISSN 0268-3369
Snowden, J.A. orcid.org/0000-0001-6819-3476, O'Connell, S., Hawkins, J. et al. (8 more authors) (2017) Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS). Journal of Clinical Pathology, 70 (6). pp. 461-468. ISSN 0021-9746
Snowden, J.A. and Hill, G.R. (2017) Conditioning regimens for autologous haematopoietic stem cell transplantation - can natural killer cell therapy help? British Journal of Haematology, 177 (3). pp. 341-342. ISSN 0007-1048
Miller, P.D., de Silva, T.I., Skinner, R. et al. (8 more authors) (2017) Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes. Bone Marrow Transplant, 52. pp. 775-777. ISSN 0268-3369
Hamblin, A., Greenfield, D.M., Gilleece, M. et al. (9 more authors) (2017) Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes. Bone Marrow Transplantation, 52. pp. 889-894. ISSN 0268-3369
Kühl, J.S., Suarez, F., Gillett, G.T. et al. (7 more authors) (2017) Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy. Brain, 140 (4). pp. 953-966. ISSN 0006-8950
Snowden, J.A., McGrath, E., Duarte, R.F. et al. (6 more authors) (2017) JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement. Bone Marrow Transplant. ISSN 0268-3369
Jones, G.L., Hughes, J., Mahmoodi, N. et al. (14 more authors) (2017) Observational study of the development and evaluation of a fertility preservation patient decision aid for teenage and adult women diagnosed with cancer: the Cancer, Fertility and Me research protocol. BMJ Open, 7 (3). e013219.
Snowden, J.A. orcid.org/0000-0001-6819-3476, Greenfield, D.M., Bird, J.M. et al. (7 more authors) (2017) Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. British Journal of Haematology, 176 (6). pp. 888-907. ISSN 0007-1048
DeFilipp, Z., Duarte, R.F., Snowden, J.A. et al. (34 more authors) (2016) Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT. Bone Marrow Transplantation. ISSN 0268-3369
Cook, G., Ashcroft, A.J., Cairns, D.A. et al. (17 more authors) (2016) The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial. Lancet Haematol, 3 (7). e340-e351.
Parrish, C., Morris, C.T.C.M., Williams, C.D. et al. (13 more authors) (2016) Stem Cell Harvesting after Bortezomib-Based Reinduction for Myeloma Relapsing after Autologous Transplantation: Results from the British Society of Blood and Marrow Transplantation/United Kingdom Myeloma Forum Myeloma X (Intensive) Trial. Biology of Blood and Marrow Transplantation, 22 (6). pp. 1009-1016. ISSN 1083-8791
Samuelson, C., O'Toole, L., Boland, E. et al. (4 more authors) (2016) High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies. Hematology, 21 (5). pp. 272-279. ISSN 1024-5332
DeFilipp, Z., Duarte, R.F., Snowden, J.A. et al. (34 more authors) (2016) Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT. Biology of Blood and Marrow Transplantation, 22 (8). pp. 1493-1503. ISSN 1083-8791
Oliveira, M.C., Labopin, M., Henes, J. et al. (15 more authors) (2016) Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients? Bone Marrow Transplant, 51 (4). pp. 501-505. ISSN 0268-3369
Berndt, S.I., Camp, N.J., Skibola, C.F. et al. (123 more authors) (2016) Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature Communications, 7. 10933. ISSN 2041-1723
Gratwohl, A., Sureda, A., Baldomero, H. et al. (16 more authors) (2015) Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study. EBioMedicine, 2 (12). pp. 2101-2109. ISSN 2352-3964
Thomas, S.J., Snowden, J.A., Zeidler, M.P. et al. (1 more author) (2015) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. British Journal of Cancer, 113 (3). 365 - 371. ISSN 0007-0920
Thomas, S., Fisher, K.H., Snowden, J.A. et al. (3 more authors) (2015) Methotrexate Is a JAK/STAT Pathway Inhibitor. PLoS ONE, 10 (7). e0130078. ISSN 1932-6203
Dalley, C., Basarir, H., Wright, J.G. et al. (13 more authors) (2015) Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model. Journal of Clinical Pathology, 68 (4). pp. 292-300. ISSN 0021-9746
Lawson, M.A., Paton-Hough, J.M., Evans, H.R. et al. (5 more authors) (2015) NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease. PLOS ONE, 10 (3). e0119546. ISSN 1932-6203
Alexander, T., Bondanza, A., Muraro, P.A. et al. (18 more authors) (2015) SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking. Bone Marrow Transplantation, 50 (2). pp. 173-180. ISSN 0268-3369
Dalley, C., Basarir, H., Wright, J. et al. (13 more authors) (2015) Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model. Journal of Clinical Pathology. Published Online First 28 January 2015. ISSN 0021-9746
Clark, J.R., Scott, S.D., Jack, A.L. et al. (14 more authors) (2015) Monitoring of chimerism following allogeneic haematopoietic stem cell transplantation (HSCT): Technical recommendations for the use of Short Tandem Repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group. British Journal of Haematology, 168 (1). 26 - 37. ISSN 0007-1048
Sloot, S., Boland, J., Snowden, J.A. et al. (9 more authors) (2014) Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study. Supportive Care in Cancer, 23 (3). pp. 671-678. ISSN 0941-4355
Boland, E.G., Selvarajah, D. orcid.org/0000-0001-7426-1105, Hunter, M. et al. (5 more authors) (2014) Central Pain Processing in Chronic Chemotherapy-Induced Peripheral Neuropathy: A Functional Magnetic Resonance Imaging Study. PLOS ONE, 9 (5). e96474. ISSN 1932-6203
Berndt, S.I., Skibola, C.F., Joseph, V. et al. (127 more authors) (2013) Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nature Genetics, 45 (8). pp. 868-876. ISSN 1061-4036
Snowden, J.A., Saccardi, R., Allez, M. et al. (17 more authors) (2012) Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 47 (6). pp. 770-790. ISSN 0268-3369
Greenfield, D.M., Absolom, K., Eiser, C. et al. (6 more authors) (2009) Follow-up care for cancer survivors: the views of clinicians. British Journal of Cancer, 101 (4). pp. 568-574. ISSN 0007-0920
Absolom, K., Eiser, C., Michel, G. et al. (6 more authors) (2009) Follow-up care for cancer survivors: views of the younger adult. British Journal of Cancer, 101 (4). pp. 561-567. ISSN 0007-0920
Proceedings Paper
Miller, P.D.E., de Silva, T. orcid.org/0000-0002-6498-9212, Leonard, H. et al. (6 more authors) (2017) P295: Viral microneutralization assay to determine seasonal influenza vaccine immunogenicity in the first year post reduced intensity conditioning allogeneic HSCT. In: Bone Marrow Transplantation. 43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26-29 Mar 2017, Marseille, France. Springer Nature , S269-S270.